BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 7947547)

  • 21. Sickle cell retinopathy in Jamaican children: further observations from a cohort study.
    Talbot JF; Bird AC; Maude GH; Acheson RW; Moriarty BJ; Serjeant GR
    Br J Ophthalmol; 1988 Oct; 72(10):727-32. PubMed ID: 2461218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripheral circumferential retinal scatter photocoagulation for treatment of proliferative sickle retinopathy.
    Cruess AF; Stephens RF; Magargal LE; Brown GC
    Ophthalmology; 1983 Mar; 90(3):272-8. PubMed ID: 6191265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Behaviour of untreated proliferative sickle retinopathy.
    Condon PI; Serjeant GR
    Br J Ophthalmol; 1980 Jun; 64(6):404-11. PubMed ID: 7387965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A screening strategy for the detection of sickle cell retinopathy in pediatric patients.
    Gill HS; Lam WC
    Can J Ophthalmol; 2008 Apr; 43(2):188-91. PubMed ID: 18347621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ocular findings in sickle cell disease patients in Lagos.
    Akinsola FB; Kehinde MO
    Niger Postgrad Med J; 2004 Sep; 11(3):203-6. PubMed ID: 15505651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Sickle cell disease and retinal damage: a study of 38 cases at the African Tropical Ophthalmology Institute (IOTA) in Bamako].
    Traoré J; Boitre JP; Bogoreh IA; Traoré L; Diallo A
    Med Trop (Mars); 2006 Jun; 66(3):252-4. PubMed ID: 16924816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patterns of visual loss in untreated sickle cell retinopathy.
    Moriarty BJ; Acheson RW; Condon PI; Serjeant GR
    Eye (Lond); 1988; 2 ( Pt 3)():330-5. PubMed ID: 3402630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent advances in the treatment of proliferative sickle cell retinopathy.
    Penman AD; Serjeant GR
    Curr Opin Ophthalmol; 1992 Jun; 3(3):379-88. PubMed ID: 10149702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retinal changes in sickle cell/hereditary persistence of fetal haemoglobin syndrome.
    Talbot JF; Bird AC; Serjeant GR
    Br J Ophthalmol; 1983 Nov; 67(11):777-8. PubMed ID: 6196049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolution of neovascularization in sickle cell retinopathy. A prospective fluorescein angiographic study.
    Raichand M; Goldberg MF; Nagpal KC; Goldbaum MH; Asdourian GK
    Arch Ophthalmol; 1977 Sep; 95(9):1543-52. PubMed ID: 561589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ocular manifestations of sickle cell disease.
    Fadugbagbe AO; Gurgel RQ; Mendonça CQ; Cipolotti R; dos Santos AM; Cuevas LE
    Ann Trop Paediatr; 2010; 30(1):19-26. PubMed ID: 20196930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proliferative sickle retinopathy and neovascularization of the disc: regression following treatment with peripheral retinal scatter laser photocoagulation.
    Kimmel AS; Magargal LE; Tasman WS
    Ophthalmic Surg; 1986 Jan; 17(1):20-2. PubMed ID: 2419814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and laboratory factors associated with the severity of proliferative sickle cell retinopathy in patients with sickle cell hemoglobin C (SC) and homozygous sickle cell (SS) disease.
    Leveziel N; Bastuji-Garin S; Lalloum F; Querques G; Benlian P; Binaghi M; Coscas G; Soubrane G; Bachir D; Galactéros F; Souied EH
    Medicine (Baltimore); 2011 Nov; 90(6):372-378. PubMed ID: 22033449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ocular manifestations of sickle-cell disease: a prevalence and natural history study.
    Clarkson JG
    Trans Am Ophthalmol Soc; 1992; 90():481-504. PubMed ID: 1494832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ophthalmologic complications in hemoglobinopathies.
    To KW; Nadel AJ
    Hematol Oncol Clin North Am; 1991 Jun; 5(3):535-48. PubMed ID: 1864821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Sickle-cell retinopathy: Retrospective study of 730 patients followed in a referral center].
    Leveziel N; Lalloum F; Bastuji-Garin S; Binaghi M; Bachir D; Galacteros F; Souied E
    J Fr Ophtalmol; 2012 May; 35(5):343-7. PubMed ID: 22472104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The angiographic pattern of the peripheral retinal vasculature.
    Asdourian GK; Goldberg MF
    Arch Ophthalmol; 1979 Dec; 97(12):2316-8. PubMed ID: 518382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epiretinal membranes in sickle cell disease.
    Moriarty BJ; Acheson RW; Serjeant GR
    Br J Ophthalmol; 1987 Jun; 71(6):466-9. PubMed ID: 3620428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trans-scleral diode laser photocoagulation in proliferative sickle cell retinopathy.
    Seiberth V
    Ophthalmology; 1999 Sep; 106(9):1828-9. PubMed ID: 10485558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal length in sickle cell disease: observations from a cohort study.
    Walker TM; Beardsall K; Thomas PW; Serjeant GR
    Clin Nephrol; 1996 Dec; 46(6):384-8. PubMed ID: 8982554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.